文献速递神经介入MR

脑转移瘤患者接受激光间质热治疗时的动态对比增强MRI:一项先导研究

Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-08-01

该先导研究前瞻性分析27例患者32个脑转移瘤共33次激光间质热治疗,评估动态对比增强MRI的iAUC60预测无进展生存的价值。术后iAUC60与无进展生存显著相关(Pearson相关P=0.03,Cox单因素分析P=0.01),而术前及1个月随访iAUC60、以及ΔiAUC60均与无进展生存无显著相关。作者认为术后iAUC60有望用于预后判断。

要点

  • 术后动态对比增强MRI的iAUC60与无进展生存显著相关(P=0.03;Cox P=0.01)。
  • 术前及1个月随访iAUC60均与无进展生存无显著相关。
  • 各时间点间ΔiAUC60与无进展生存均无统计学显著关系。

核心结论

  • 术后动态对比增强MRI提取的iAUC60显示出准确预测激光间质热治疗后患者预后的前景。
  • 由于治疗后改变混杂,接受激光间质热治疗的脑转移瘤患者无进展生存难以预测。

研究设计与样本

  • 先导研究,前瞻性分析连续系列接受激光间质热治疗的脑转移瘤患者。
  • 共33次激光间质热治疗、32个脑转移瘤、27例患者。
  • 前瞻性收集年龄、性别、肿瘤组织学和Karnofsky功能状态评分。
  • 分析术前、术后及1个月随访的动态对比增强MRI,iAUC60采用梯形法则计算增强后前60秒对比剂摄取的时间曲线下面积。
  • ΔiAUC60为两个时间点iAUC60值之差;无进展生存定义为从激光间质热治疗至肿瘤复发的时间。

诊断标准与关键数值

  • 术后动态对比增强MRI的iAUC60与无进展生存显著相关:Pearson相关P=0.03,Cox单因素分析P=0.01。
  • 术前及1个月随访动态对比增强MRI的iAUC60与无进展生存无显著相关。
  • 各时间点间ΔiAUC60与无进展生存均无统计学显著关系。

临床应用与阅片要点

  • 作者认为术后动态对比增强MRI提取的iAUC60有望用于预测接受激光间质热治疗的脑转移瘤患者的预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Tumor recurrence is difficult to predict in patients receiving laser ablation for intracranial malignancy. We assessed the efficacy of the initial area under the time-to-signal intensity curve at 60 seconds (iAUC60) from dynamic contrast-enhanced MR imaging in predicting progression-free survival in patients with brain metastases following laser interstitial thermal therapy.

MATERIALS AND METHODS: The study population was a consecutive series of patients undergoing laser interstitial thermal therapy for brain metastases. Patient demographics including age, sex, tumor histology, and Karnofsky Performance Scale were collected prospectively. Preoperative, postoperative, and 1-month follow-up dynamic contrast-enhanced MRIs were analyzed. Values of iAUC60 were computed using a trapezoidal rule applied to the time history of contrast uptake over the first 60 seconds postenhancement. The change in iAUC60 (ΔiAUC60) was calculated by taking the difference between the values of iAUC60 from 2 time points. Pearson correlation coefficients were calculated between progression-free survival, defined as the time from laser interstitial thermal therapy to tumor recurrence, and iAUC60 or ΔiAUC60 values.

RESULTS: Thirty-three cases of laser interstitial thermal therapy for 32 brain metastases in a cohort of 27 patients were prospectively analyzed. A significant relationship was observed between the values of iAUC60 from postoperative dynamic contrast-enhanced MR imaging and progression-free survival with Pearson correlation (P = .03) and Cox univariate analysis (P = .01). The relationship between preoperative and 1-month follow-up dynamic contrast-enhanced MR imaging was not significantly correlated with progression-free survival. Similarly, no statistically significant relationship was observed with ΔiAUC60 and progression-free survival between any time points.

CONCLUSIONS: Progression-free survival is difficult to predict in patients undergoing laser interstitial thermal therapy for brain metastases due to confounding with posttreatment change. iAUC60 extracted from postoperative dynamic contrast-enhanced MR imaging shows promise for accurately prognosticating patients following this operative therapy.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Traylor JI, Bastos DCA, Fuentes D, et al. Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study. AJNR Am J Neuroradiol. 2019. PMID: 31371353. doi:10.3174/ajnr.A6144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。